Main public logs
Jump to navigation
Jump to search
Combined display of all available logs of Azupedia. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 15:53, 12 February 2024 Fire talk contribs created page formaldehyde dehydrogenase activity (Q20845) (wbeditentity-create:2|en: formaldehyde dehydrogenase activity, Catalysis of the reaction: formaldehyde + H(2)O + NAD(+) = formate + 2 H(+) + NADH.)
- 15:52, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/12/ja (Created page with "2017年のメタアナリシスでは、GLP-1作動薬またはDPP-4阻害薬による治療が2型糖尿病患者の全死亡を増加させるという示唆は支持されなかった。")
- 15:43, 12 February 2024 Fire talk contribs created page acireductone dioxygenase [iron(II)-requiring] activity (Q20844) (wbeditentity-create:2|en: acireductone dioxygenase [iron(II)-requiring] activity, Catalysis of the reaction: 1,2-dihydroxy-5-(methylthio)pent-1-en-3-one + O(2) = 4-methylthio-2-oxobutanoate + formate + H(+).)
- 15:42, 12 February 2024 Fire talk contribs created page acireductone dioxygenase (Ni2+-requiring) activity (Q20843) (wbeditentity-create:2|en: acireductone dioxygenase (Ni2+-requiring) activity, Catalysis of the reaction: 1,2-dihydroxy-5-(methylthio)pent-1-en-3-one + O(2) = 3-(methylthio)propanoate + CO + formate.)
- 15:40, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/11/ja (Created page with "この医薬品の第3相臨床試験プログラムでは、0.75 mgと1.5 mgの用量でヘモグロビンA1cが約1％減少し、平均で約5ポンドの体重減少が認められた。2020年に承認された3.0& mgと4.5& mgの高用量では、ヘモグロビンA1cの減少が1.5%に近く、体重減少もわずかに多かった。")
- 15:38, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/10/ja (Created page with "==医薬用途== {{Anchor|Medical uses}} 本薬は、血糖コントロールを改善するための食事療法および運動療法の補助薬として、成人の2型糖尿病に適応を有する。デュラグルチドは、1型糖尿病患者または糖尿病性ケトアシドーシス患者の治療には適応されない。なぜなら、これらの問題は膵島細胞がインスリンを産生できない結果であり、デュラグルチドの作用の...")
- 15:36, 12 February 2024 Fire talk contribs created page aldehyde decarbonylase activity (Q20842) (wbeditentity-create:2|en: aldehyde decarbonylase activity, Catalysis of the reaction: a C(n) aldehyde = C(n-1) alkane + CO.)
- 15:36, 12 February 2024 Fire talk contribs created page octadecanal decarbonylase activity (Q20841) (wbeditentity-create:2|en: octadecanal decarbonylase activity, Catalysis of the reaction: octadecanal = heptadecane + CO.)
- 10:44, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/9/ja (Created page with "本薬は、GLP-1(7-37)をヒトIgG4のFcフラグメントと共有結合させたグルカゴン様ペプチド-1受容体作動薬（GLP-1作動薬）である。GLP-1は、血中グルコース濃度（血糖値）の正常化に関与するホルモンである。米国では2014年9月に食品医薬品局（FDA）がデュラグルチドの使用を...")
- 10:42, 12 February 2024 Fire talk contribs created page formyltetrahydrofolate deformylase activity (Q20840) (wbeditentity-create:2|en: formyltetrahydrofolate deformylase activity, Catalysis of the reaction: 10-formyltetrahydrofolate + H(2)O = (6S)-5,6,7,8-tetrahydrofolate + formate + H(+).)
- 10:41, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/8/ja (Created page with "最も一般的な副作用は、吐き気、下痢、嘔吐、腹痛、食欲低下である。")
- 10:39, 12 February 2024 Fire talk contribs created page formate dehydrogenase (NAD+) activity (Q20839) (wbeditentity-create:2|en: formate dehydrogenase (NAD+) activity, Catalysis of the reaction: formate + NAD(+) = CO(2) + NADH.)
- 10:36, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/7/ja (Created page with "'''デュラグルチド'''（'''Dulaglutide'''）は、特に'''トルリシティ'''('''Trulicity''')というブランド名で販売されており、2型糖尿病の治療に用いられる医薬品で、食事療法と運動療法を併用する。また、米国では、確立した心血管疾患または複数の心血管危険因子を有する成人の2型糖尿病患者におけるmajor...")
- 10:32, 12 February 2024 Fire talk contribs created page C-acetyltransferase activity (Q20838) (wbeditentity-create:2|en: C-acetyltransferase activity, Catalysis of the transfer of an acetyl group to a carbon atom on the acceptor molecule.)
- 10:32, 12 February 2024 Fire talk contribs created page formate C-acetyltransferase activity (Q20837) (wbeditentity-create:2|en: formate C-acetyltransferase activity, Catalysis of the reaction: acetyl-CoA + formate = CoA + pyruvate.)
- 10:31, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/6/ja (Created page with "<!-- Chemical and physical data --> | IUPAC_name = | C = 2646 | H = 4044 | N = 704 | O = 836 | S = 18 | SMILES = | StdInChI = | StdInChI_comment = | StdInChIKey = | density = | density_notes = | melting_point = | melting_high = | melting_notes = | boiling_point = | boiling_notes = | solubility...")
- 10:31, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/5/ja (Created page with "<!-- Identifiers --> | CAS_number_Ref = | CAS_number = 923950-08-7 | CAS_supplemental = | PubChem = | PubChemSubstance = | IUPHAR_ligand = 7638 | DrugBank_Ref = | DrugBank = DB09045 | ChemSpiderID_Ref = | ChemSpiderID = | UNII_Ref = | UNII = WTT295HSY5 | KEGG_Ref = | KEGG = D09889 | ChEBI_Ref = | ChEBI = | ChEMBL_Ref = | ChEMBL...")
- 10:31, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/4/ja (Created page with "<!-- Pharmacokinetic data --> | bioavailability = | protein_bound = | metabolism = | metabolites = | onset = | elimination_half-life = | duration_of_action = | excretion =")
- 10:31, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/3/ja (Created page with "<!-- Legal status --> | legal_AU = S4 | legal_AU_comment = | legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F--> | legal_BR_comment = | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_CA_comment = | legal_DE = <!-- Anlage I, II, III or Unscheduled--> | legal_DE_comment = | legal_NZ = <!-- Class A, B, C --> | legal_NZ_comment = | legal_UK =...")
- 10:30, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/2/ja (Created page with "<!-- Clinical data --> | pronounce = | tradename = Trulicity, others | Drugs.com = {{Drugs.com|monograph|dulaglutide}} | MedlinePlus = a614047 | DailyMedID = Dulaglutide | pregnancy_AU = B3 | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = Subcutaneous | class = Incretin mimetic/ja | ATCvet = | ATC_prefix = A10 | ATC_suffix...")
- 10:30, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/1/ja (Created page with "{{Drug List/ja|state6=uncollapsed}} {{Pathnav|Medication/ja|Diabetes medication/ja|GLP-1 receptor agonist/ja|frame=1}} {{Infobox drug | image = Autoinjector with Trulicity by Lilly (Dulaglutid)-3129.jpg | width = | alt = リリー社製トルリシティ配合自動注射器 | caption =")
- 10:29, 12 February 2024 Fire talk contribs created page Dulaglutide/ja (Created page with "デュラグルチド")
- 10:29, 12 February 2024 Fire talk contribs created page Translations:Dulaglutide/Page display title/ja (Created page with "デュラグルチド")
- 10:29, 12 February 2024 Fire talk contribs marked Dulaglutide for translation
- 10:29, 12 February 2024 Fire talk contribs limited languages for translatable page Dulaglutide to Japanese
- 10:27, 12 February 2024 Fire talk contribs created page Template:Infobox drug/legal status/doc/options (Created page with "{{align|right|{{nowrap|1=<small>This options list:</small> {{view||edit|template=Infobox drug/legal status/doc/options}}}}}}{{clear}} :Parameter naming pattern: {{para|legal_XX}}, {{para|legal_XX_comment}}. :<code>XX</code> can be: AU, BR, CA, DE, NZ, UK, US; UN and EU :For general input: {{para|legal_status}} {| class="wikitable collapsible {{{state|uncollapsed}}}" style="width:100%; font-size:90%" |- ! colspan=2 style="text-align:center;" | Standard {{para|legal_...}}...")
- 10:26, 12 February 2024 Fire talk contribs created page Category:Drugs with non-standard legal status (Created page with "{{hidden category}}{{empty category}} {{tl|Infobox drug}} and {{tl|Chembox}} articles that have a legal status that is not in the list of known Schemes. Known schemes are pre-formatted for: AU, DE, CA, NZ, UK, US, UN, EU (see documentation below). * See also: {{cl|Drugs with no legal status}} ({{para|legal_??}} is empty) {{Template:Infobox drug/legal status/doc/options|state=collapsed}} ;Maintenance tasks * Listed ''' ''' (blank): {{para|legal status}} has regula...")
- 10:26, 12 February 2024 Fire talk contribs created page Category:Peptide therapeutics (Created page with "{{cat main}} Category:Peptides Category:Drugs by structure")
- 10:25, 12 February 2024 Fire talk contribs created page Category:Drugs developed by Eli Lilly and Company (Created page with "{{Cat main|Eli Lilly and Company}} Category:Brands by company Category:Drug brand names Category:Health care brands Brands {{CatAutoTOC}}")
- 10:19, 12 February 2024 Fire talk contribs created page 3,4-dihydroxy-2-butanone-4-phosphate synthase activity (Q20836) (wbeditentity-create:2|en: 3,4-dihydroxy-2-butanone-4-phosphate synthase activity, Catalysis of the reaction: D-ribulose 5-phosphate = (2S)-2-hydroxy-3-oxobutyl phosphate + formate + H(+).)
- 10:16, 12 February 2024 Fire talk contribs created page formylmethionine deformylase activity (Q20835) (wbeditentity-create:2|en: formylmethionine deformylase activity, Catalysis of the reaction: N-formyl-L-methionine + H(2)O = L-methionine + formate.)
- 10:14, 12 February 2024 Fire talk contribs created page glucose intolerance (Q20834) (wbeditentity-create:2|en: glucose intolerance, pre-diabetic state of hyperglycemia that is associated with insulin resistance and increased risk of cardiovascular pathology. IGT may precede type 2 diabetes mellitus by many years)
- 10:10, 12 February 2024 Fire talk contribs created page demethylase activity (Q20833) (wbeditentity-create:2|en: demethylase activity, Catalysis of the removal of a methyl group from a substrate.)
- 10:09, 12 February 2024 Fire talk contribs created page sterol 14-demethylase activity (Q20832) (wbeditentity-create:2|en: sterol 14-demethylase activity, Catalysis of the reaction: obtusifoliol + 3 O2 + 3 NADPH + 3 H+ = 4-alpha-methyl-5-alpha-ergosta-8,14,24(28)-trien-3-beta-ol + formate + 3 NADP+ + 3 H2O.)
- 10:08, 12 February 2024 Fire talk contribs created page eating behavior (Q20831) (wbeditentity-create:2|en: eating behavior, specific behavior of an organism relating to the intake of food, any substance (usually solid) that can be metabolized by an organism to give energy and build tissue)
- 10:07, 12 February 2024 Fire talk contribs created page disordered eating (Q20830) (wbeditentity-create:2|en: disordered eating, any of several abnormal eating behaviors)
- 10:06, 12 February 2024 Fire talk contribs created page eating disorder (Q20829) (wbeditentity-create:2|en: eating disorder, habit of eating either insufficient or excessive food, to the detriment of health)
- 10:05, 12 February 2024 Fire talk contribs created page polyphagia (Q20828) (wbeditentity-create:2|en: polyphagia, excessive hunger or increased appetite)
- 10:02, 12 February 2024 Fire talk contribs created page formate-tetrahydrofolate ligase activity (Q20827) (wbeditentity-create:2|en: formate-tetrahydrofolate ligase activity, Catalysis of the reaction: ATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate.)
- 10:01, 12 February 2024 Fire talk contribs created page diuresis (Q20826) (wbeditentity-create:2|en: diuresis, increase in urine production)
- 09:59, 12 February 2024 Fire talk contribs created page formamidase activity (Q20825) (wbeditentity-create:2|en: formamidase activity, Catalysis of the reaction: formamide + H(2)O = formate + NH(4)(+).)
- 09:57, 12 February 2024 Fire talk contribs created page 24-hour urine volume (Q20824) (wbeditentity-create:2|en: 24-hour urine volume)
- 09:57, 12 February 2024 Fire talk contribs created page polyuria (Q20823) (wbeditentity-create:2|en: polyuria, excessive or abnormally large production or passage of urine)
- 09:56, 12 February 2024 Fire talk contribs created page arylformamidase activity (Q20822) (wbeditentity-create:2|en: arylformamidase activity, Catalysis of the reaction: N-formyl-L-kynurenine + H2O = formate + L-kynurenine.)
- 09:54, 12 February 2024 Fire talk contribs created page diabetology (Q20821) (wbeditentity-create:2|en: diabetology, clinical science of diabetes mellitus)
- 21:50, 11 February 2024 Fire talk contribs created page autoimmune disease of endocrine system (Q20820) (wbeditentity-create:2|en: autoimmune disease of endocrine system, hypersensitivity reaction type II disease that is the abnormal functioning of the immune system resulting in production of antibodies or T cells against cells and/or tissues in the endocrine system)
- 21:49, 11 February 2024 Fire talk contribs created page type-1 diabetes (Q20819) (wbeditentity-create:2|en: type-1 diabetes, form of diabetes mellitus)
- 21:47, 11 February 2024 Fire talk contribs created page GTP cyclohydrolase II activity (Q20818) (wbeditentity-create:2|en: GTP cyclohydrolase II activity, Catalysis of the reaction: GTP + 3 H(2)O = 2,5-diamino-6-hydroxy-4-(5-phosphoribosylamino)-pyrimidine + diphosphate + formate + 3 H(+).)
- 21:45, 11 February 2024 Fire talk contribs created page fusion protein (Q20817) (wbeditentity-create:2|en: fusion protein, protein created by joining other proteins into a single polypeptide)
- 21:44, 11 February 2024 Fire talk contribs created page dulaglutide (Q20816) (wbeditentity-create:2|en: dulaglutide, pharmaceutical drug)